{"id":"W4306843199","doi":"10.1182/bloodadvances.2022008747","title":"An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; National Institutes of Health; Astellas Pharma; Incyte; Astex Pharmaceuticals; Gilead Sciences; Jazz Pharmaceuticals; Leukemia and Lymphoma Society; Acceleron; Celgene; Bristol-Myers Squibb; AstraZeneca; National Institute of Diabetes and Digestive and Kidney Diseases; Cardinal Health; Amgen; National Heart, Lung, and Blood Institute; Pfizer; National Center for Advancing Translational Sciences; Agios Pharmaceuticals","keywords":"Myelodysplastic syndromes; MEDLINE; Medicine; Computer science; Political science; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06657372,0.003279068,0.004746342,0.004948556,0.004974531,0.01960842,0.004165754,0.02366282,0.03235517],"category_scores_gemma":[0.04470975,0.001643735,0.005191996,0.003282178,0.004398219,0.01646107,0.01880222,0.03472177,0.01205826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01043824,"about_ca_system_score_gemma":0.09499187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005126325,"about_ca_topic_score_gemma":0.01201916,"domain_scores_codex":[0.9738985,0.008229208,0.002485264,0.001482231,0.006598253,0.007306436],"domain_scores_gemma":[0.8787568,0.02243662,0.003318404,0.002016731,0.02896852,0.06450303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004844589,0.0003156065,0.0009794657,0.00407095,0.0001246733,0.0003663067,0.000409154,0.0003820899,0.0009575236,0.01207537,0.840458,0.1393764],"study_design_scores_gemma":[0.0004351485,0.0003628221,0.00217616,0.009402946,0.0001792947,0.0003237712,0.002047163,0.0003167625,0.0003344215,0.01890356,0.9654045,0.0001135181],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.0006851622,0.1125119,0.001954756,0.770233,0.1069611,0.0001680315,0.0004424241,0.0002626111,0.006781107],"genre_scores_gemma":[0.01888442,0.2903179,0.02840302,0.5014901,0.1341538,0.0009303771,0.003872436,0.0004524978,0.02149545],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.06657372,"threshold_uncertainty_score":0.3520797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04899527071681768,"score_gpt":0.3902732719126943,"score_spread":0.3412780011958766,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}